Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sanofi - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SNY
Nasdaq
2834
www.sanofi.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sanofi
The Top 5 Analyst Questions From Novavax’s Q1 Earnings Call
- May 16th, 2026 2:12 pm
Sanofi’s vaccine bump; the new FDA commish
- May 15th, 2026 4:29 am
Trinity's TGaS Advisors Announces Winners of 9th Annual Best of Benchmark Awards
- May 12th, 2026 6:00 am
Sanofi Leans On AI And Rare Disease Detection To Shape Future Returns
- May 9th, 2026 1:13 am
The Agencies Building Pharma's Next Decade Just Picked Their Software: Daily Command Launches With 18 of the Industry's Most Senior Agency Leaders Already Inside It
- May 7th, 2026 4:00 pm
75 of Pharma's Most Senior Marketers Just Walked Away From a $12 Billion Tool Stack
- May 7th, 2026 3:15 pm
RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
- May 7th, 2026 9:30 am
Nexviazyme (Sanofi: avalglucosidase alfa-ngpt) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
- May 7th, 2026 9:26 am
IgG4-Related Disease Market Analysis and Forecasts, 2025-2026 & 2035 with Amgen, Zenas BioPharma, Bristol Myers Squibb, and Sanofi Leading
- May 7th, 2026 5:34 am
Vicore Pharma Elects Peter Guenter to its Board of Directors
- May 7th, 2026 12:20 am
Novavax, Inc. Q1 2026 Earnings Call Summary
- May 6th, 2026 2:50 pm
This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout
- May 6th, 2026 2:07 pm
Sanofi’s Dynavax Deal Reshapes Vaccine Portfolio And Valuation Narrative
- May 6th, 2026 11:14 am
Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1
- May 6th, 2026 10:41 am
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights
- May 6th, 2026 6:00 am
BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised
- May 5th, 2026 11:17 am
Regeneron (REGN) Dupixent Phase 4 Trial Results Show Improved Esophageal Function in EoE
- May 5th, 2026 8:14 am
Zifo's SiEE Boston Summit Charts New Roadmap for 'Practical AI' in Life Sciences, Bridging the Gap Between Business Vision and Lab Reality
- May 5th, 2026 7:00 am
Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial
- May 5th, 2026 5:00 am
Sanofi invests $294M to expand AI Center of Excellence in Toronto and accelerate innovation for patients
- May 4th, 2026 11:00 am
Scroll